RNF8–CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype and exhibits an overall poor outcome. Due to the lack of targeted therapy, conventional systemic chemotherapy has been the main strategy for the treatment of TNBC. Further evidence has shown that combining radiation wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kao, Chieh-Ni, Moi, Sin-Hua, Hou, Ming-Feng, Luo, Chi-Wen, Chen, Fang-Ming, Pan, Mei-Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307233/
https://www.ncbi.nlm.nih.gov/pubmed/34357122
http://dx.doi.org/10.3390/jpm11070655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307233/
https://www.ncbi.nlm.nih.gov/pubmed/34357122
http://dx.doi.org/10.3390/jpm11070655

Ejemplares similares